2020
DOI: 10.1002/jac5.1201
|View full text |Cite
|
Sign up to set email alerts
|

Credentialing and privileging for clinical pharmacists

Abstract: The American College of Clinical Pharmacy (ACCP) 2019 Certification AffairsCommittee was charged with writing a white paper to provide a road map for developing initial and ongoing credentialing and privileging processes for clinical pharmacists. After extensively reviewing the literature, the committee prepared a framework to support organizations in implementing credentialing and privileging programs. This document contains definitions, principles, and a suggested process for credentialing; organizational co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…[27][28][29] Clinical activities, considerations, and a framework for implementing credentialing and privileging have been described elsewhere, and this continues to be an area of growth for oncology pharmacy. 26,30 Overall, pharmacy technicians represented a large proportion of the total oncology pharmacy FTEs (median 11 (Q0: 1, Q1: 4, Q3: 30, Q4: 220)) out of a total pharmacy FTE of median 16 (Q0: 1, Q1: 5, Q3: 60, Q4: 570). However, there appeared to be a much higher proportion of total oncology FTEs devoted to pharmacy technicians at community as compared to academic institutions.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[27][28][29] Clinical activities, considerations, and a framework for implementing credentialing and privileging have been described elsewhere, and this continues to be an area of growth for oncology pharmacy. 26,30 Overall, pharmacy technicians represented a large proportion of the total oncology pharmacy FTEs (median 11 (Q0: 1, Q1: 4, Q3: 30, Q4: 220)) out of a total pharmacy FTE of median 16 (Q0: 1, Q1: 5, Q3: 60, Q4: 570). However, there appeared to be a much higher proportion of total oncology FTEs devoted to pharmacy technicians at community as compared to academic institutions.…”
Section: Discussionmentioning
confidence: 99%
“…The number of organizations that have an individual credentialing and privileging system in place correlated with the number of oncology pharmacy FTEs, BCOP certification, and PGY2 training. 26 Implementing institutional credentialing and privileging through collaborative practice agreements can decrease costs, prevent chemotherapy errors, and increase staff satisfaction. 27 29 Clinical activities, considerations, and a framework for implementing credentialing and privileging have been described elsewhere, and this continues to be an area of growth for oncology pharmacy.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…32 outpatient settings, predefined qualifications and competencies that encompass a combination of clinical knowledge, oncology expertise, and patient-centered care are needed in Saudi Arabia. 46…”
Section: Qualifications and Competencies For Ambulatory Care Oncology...mentioning
confidence: 99%
“…An ID pharmacist CPA can expand available services to patients, increase the efficiency and coordination of care, and leverage pharmacists' medication expertise to complement the skills and knowledge of the other health care team members 32 . An OPAT/COpAT CPA should (a) define the scope of care provided including the OPAT/COpAT care setting(s), the OPAT/COpAT population, and OPAT/COpAT services to be delivered by the pharmacist; (b) identify the pharmacist's scope of practice as defined by state law; (c) determine the pharmacist scope of practice including the duties or tasks and the amount of oversight provided by prescribers; and (d) define the pharmacist‐required qualifications and competencies 33 . Ideally, the ID pharmacist at a minimum has allowances to independently order and evaluate applicable labs, adjust antimicrobial doses, provide supportive care prescriptions (flushes, anti‐emetics, etc.…”
Section: Future Directionsmentioning
confidence: 99%